State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans
- PMID: 24270606
- PMCID: PMC3828229
- DOI: 10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8
State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans
Abstract
Background: Between September 2012 and 22 October 2013, 144 laboratory-confirmed and 17 probable MERS-CoV cases from nine countries were notified to WHO.
Methods: We summarize what is known about the epidemiology, virology, phylogeny and emergence of MERS-CoV to inform public health policies.
Results: The median age of patients (n=161) was 50 years (range 14 months to 94 years), 64.5% were male and 63.4% experienced severe respiratory disease. 76.0% of patients were reported to have ≥1 underlying medical condition and fatal cases, compared to recovered or asymptomatic cases were more likely to have an underlying condition (86.8% vs. 42.4%, p<0.001). Analysis of genetic sequence data suggests multiple independent introductions into human populations and modelled estimates using epidemiologic and genetic data suggest R0 is <1, though the upper range of estimates may exceed 1. Index/sporadic cases (cases with no epidemiologic-link to other cases) were more likely to be older (median 59.0 years vs. 43.0 years, p<0.001) compared to secondary cases, although these proportions have declined over time. 80.9% vs. 67.2% of index/sporadic and secondary cases, respectively, reported ≥1 underlying condition. Clinical presentation ranges from asymptomatic to severe pneumonia with acute respiratory distress syndrome and multi-organ failure. Nearly all symptomatic patients presented with respiratory symptoms and 1/3 of patients also had gastrointestinal symptoms.
Conclusions: Sustained human-to-human transmission of MERS-CoV has not been observed. Outbreaks have been extinguished without overly aggressive isolation and quarantine suggesting that transmission of virus may be stopped with implementation of appropriate infection control measures.
Figures
Similar articles
-
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.Curr Opin Pulm Med. 2014 May;20(3):233-41. doi: 10.1097/MCP.0000000000000046. Curr Opin Pulm Med. 2014. PMID: 24626235 Review.
-
[Etiological, epidemiological and clinical aspects of coronavirus infection MERS-CoV].Pol Merkur Lekarski. 2015 Jan;38(223):46-50. Pol Merkur Lekarski. 2015. PMID: 25763589 Review. Polish.
-
Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers.Curr Opin Infect Dis. 2014 Oct;27(5):411-7. doi: 10.1097/QCO.0000000000000089. Curr Opin Infect Dis. 2014. PMID: 25033169 Review.
-
Unanswered questions about the Middle East respiratory syndrome coronavirus (MERS-CoV).BMC Res Notes. 2014 Jun 11;7:358. doi: 10.1186/1756-0500-7-358. BMC Res Notes. 2014. PMID: 24920393 Free PMC article.
-
Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection.Ann Intern Med. 2014 Mar 18;160(6):389-97. doi: 10.7326/M13-2486. Ann Intern Med. 2014. PMID: 24474051
Cited by 157 articles
-
Society for Advanced Bronchoscopy Consensus Statement and Guidelines for bronchoscopy and airway management amid the COVID-19 pandemic.J Thorac Dis. 2020 May;12(5):1781-1798. doi: 10.21037/jtd.2020.04.32. J Thorac Dis. 2020. PMID: 32642084 Free PMC article. Review. No abstract available.
-
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.Am J Med Sci. 2020 Jul;360(1):5-34. doi: 10.1016/j.amjms.2020.05.006. Epub 2020 May 11. Am J Med Sci. 2020. PMID: 32620220 Free PMC article. Review.
-
Epidemiological and Clinical Characteristics of Cases During the Early Phase of COVID-19 Pandemic: A Systematic Review and Meta-Analysis.Front Med (Lausanne). 2020 Jun 11;7:295. doi: 10.3389/fmed.2020.00295. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32596248 Free PMC article.
-
The neurological insights of the emerging coronaviruses.J Clin Neurosci. 2020 Aug;78:1-7. doi: 10.1016/j.jocn.2020.06.006. Epub 2020 Jun 11. J Clin Neurosci. 2020. PMID: 32563494 Free PMC article. Review.
-
Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury.Stem Cell Res Ther. 2020 May 24;11(1):192. doi: 10.1186/s13287-020-01699-3. Stem Cell Res Ther. 2020. PMID: 32448377 Free PMC article. Review.
References
-
- Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012 Nov 8;367(19):1814-20. PubMed PMID:23075143. - PubMed
-
- Bermingham A, Chand MA, Brown CS, Aarons E, Tong C, Langrish C, Hoschler K, Brown K, Galiano M, Myers R, Pebody RG, Green HK, Boddington NL, Gopal R, Price N, Newsholme W, Drosten C, Fouchier RA, Zambon M. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill. 2012 Oct 4;17(40):20290. PubMed PMID:23078800. - PubMed
-
- Hijawi B, Abdallat M, Sayaydeh A, Alqasrawi S, Haddadin A, Jaarour N, Alsheikh S, Alsanouri T. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J. 2013;19 Suppl 1:S12-8. PubMed PMID:23888790. - PubMed
-
- WHO (2012-2013) World Health Organization. Global Alert and Response. Coronavirus Infections. Available at: http://wwwwhoint/csr/disease/coronavirus_infections/en/
-
- Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med. 2013 Jun 27;368(26):2487-94. PubMed PMID:23718156. - PubMed
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources